Journals / İnönü Üniversitesi Tıp Fakültesi Dergisi / 2003 / Cilt: 10 - Sayı: 2

Long term results of memotherm stent treatment in patients with recurrent urethral stenosis

Rekürren üretra darlıklarında uygulanan memotherm üretral stentlerin uzun dönem sonuçları

Pages
67–69
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

They should not be the first treatment in patients with severe periurethral fibrosis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: We have evaluated the long term efficacy and safety of permanent urethral stents (Memotherm) in patients with recurrent urethral strictures.
📊
Key Findings & Data:Material and method: Between 1994 and 2001, 13 patients underwent Memotherm stenting following endoscopy and radial internal urethrotomy for recurrent urethral strictures.
💡
Conclusion & Impact:They should not be the first treatment in patients with severe periurethral fibrosis.
🔬Design:Research Article
📍Scope:2001 Verileri
⚙️Variables:Domain Parameters

Abstract

Purpose: We have evaluated the long term efficacy and safety of permanent urethral stents (Memotherm) in patients with recurrent urethral strictures. Material and method: Between 1994 and 2001, 13 patients underwent Memotherm stenting following endoscopy and radial internal urethrotomy for recurrent urethral strictures. Patients were followed-up for a mean of 58 months by uroflowmetry, urinary system ultrasonography and retrograde urethrograms. Results: After stenting, 85% of the cases were successful, either with a complete (70%) or partial (15%) response. Mean maximum flow rate was found to be 21,5 ±7,2 ml/sec. During the postoperative perical partial stenozis due to in-stent epithelial hyperplasia was seen in two (15%) and recurrent stenosis proximal to the stent was also seen in another two (15%) patients. Complications were minimal stress incontinance with terminal dribbling in two patients and painful intercourse in another patient which lasted in a couple weeks. Discussion: Permanent urethral stents should be the first choice of treatment in recurrent and uncomplicated urethral strictures because of the ease of application, minimal invasiveness and low complication rates. They should not be the first treatment in patients with severe periurethral fibrosis.

Özet

Amaç: Tekrarlayan üretra darlıklı hastalarda kalıcı üretral stentlerin (Memotherm) uzun dönemde etkinliği ve güvenilirliğini değerlendirdik. Materyal ve metod: 1994-2001 yılları arasında 13 hastaya tekrarlayan üretra darlığı nedeniyle endoskopi ve radier internal üretrotomiyi takiben Memotherm üretral stent uygulandı.Olgular üroflovmetri,üriner sistem ultrasonografisi ve retrograd üretrogram ile ortalama 58 ay takip edildi. Sonuçlar: Stent sonrası hastaların % 85’ inde tam(%70) veya kısmi başarı (%15) gözlendi.Üroflovmetrik olarak maksimum akım hızı ortalamaları 21,5 ml/sn (±7,2) olarak bulundu.2 hastada (%15) stent içi epitel hiperplazisine bağlı kısmi darlık, yine 2 hastada da (%15) stent proksimalinde nüks darlık tespit edildi. Komplikasyon olarak 2 hastada 1 yıl süren minimal stres inkontinans ve idrar sonrası damlama, 1 hastada kısa sürede düzelen koitus sırasında ağrı gözlendi. Tartışma: Kalıcı üretral stentler özellikle nüks, komplike olmayan darlıklarda kolay uygulanabilir, minimal invaziv olması ve düşük komplikasyon oranlarıyla ilk seçenek tedavi olabilir.Ciddi periüretral fibrozisli olgularda ilk tedavi olarak tercih edilmemelidir.

🔖

Cite This Article

KILIÇ, S., UĞRAŞ, M., SOYLU, A., GÜNEŞ, A., BAYDİNÇ, C., ALTINOLUK, B. (2022). Long term results of memotherm stent treatment in patients with recurrent urethral stenosis. İnönü Üniversitesi Tıp Fakültesi Dergisi, Cilt: 10 - Sayı: 2, 67–69. https://ajindex.com/articles/548894

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Milroy EJG, Chapple CR, Cooper JE et al. A new treatment for urethral strictures. Lancet 1988; i: 1424-1427
  2. Braf Zvi, Chen Juza, Sofer Mario et al.Intraprostatic metal stents more than 6 years clinical experience with 110 patients. J Endourology 1996;10(6): 555-558
  3. Parikh AM, Milroy EJG. Precautions and complications in the use of the Urolume wallstent.Eur Urol.1995;27: 1-7
  4. Wilson TS, Lemack GE and Dmochowski RR. Urolume stents: Lessons learned.J Urol.2002;167:2477-2480
  5. Sachse H. Zur behandlung der Harnröhrenstriktur: Die transurethrale Schlitzung unter sicht mit scharfem Schnitt.Fortschr Med.1974;92: 12
  6. Milroy EJG, Chapple CR, Eldin A et al. A new treatment for urethral strictures: a permanently implanted urethral stent. J Urol.1989;141:1120
  7. Milroy EJG, Allen A. Long term results of Urolume urethral stent for recurrent urethral strictures.J Urol.1996;155:904-908
  8. Isotalo T, Talja M, Valimaa T et al. A bioabsorbable self expandable, self reinforced poly-L-lactic acid urethral stent for recurrent urethral strictures:Long term results.J Endourol 2002;16(10):759-762
  9. Campuzano P, Gonzalez SC, Rodriguez TJ et al.Treatment of urethral stenosis with thermo-expandable prosthesis (Memotherm) our experience.Arch Esp Urol.2000;53(3):253-258.(Abstract
  10. Tillem SM, Press SM, Badlani GH.Use of multipl Urolume endourethral prosthesis in complex bulbar urethral strictures.J Urol. 1997;157:1665-1668.